Clinical Trial Update: Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen Allergens [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting safety and efficacy of aluminium hydroxide-adsorbed birch pollen allergoid immunotherapy for birch pollen allergy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Birch Pollen Allergy
• Pollen Allergy

Drugs mentioned

• Birch Pollen Allergoid Immunotherapy (Aluminium hydroxide-adsorbed) (birch pollen allergoid immunotherapy)

Snippet

Sponsor: Allergopharma GmbH & Co. KG | Conditions: Pollen Allergy | Phase 3 | Status: COMPLETED